GO:0120548 phosphatidylinositol phospholipase C activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0120548 phosphatidylinositol phospholipase C activity describes the hydrolysis of phosphatidylinositol into inositol 1-phosphate and diacylglycerol, a reaction that generates two distinct lipid-derived signals.
• The term is a molecular_function in the Gene Ontology and is distinct from broader phospholipase C activities because its substrate is a phosphatidylinositol lipid.
• Enzymes with this activity include bacterial phosphatidylinositol-specific phospholipase C and eukaryotic phospholipase C isoforms that act on phosphoinositides.
• In plants, phosphatidylinositol-specific phospholipase C sits at the center of innate immunity signaling and calcium influx regulation.
• In humans, dysregulated phospholipase C signaling is linked to brain disorders, immune dysregulation and Alzheimer disease models.
• Studying this activity requires combining lipid biochemistry, calcium imaging, genetic perturbation and CRISPR-based cell models.
Description
GO:0120548 phosphatidylinositol phospholipase C activity is a Gene Ontology molecular_function term that captures the catalytic hydrolysis of a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) substrate into 1D-myo-inositol 1-phosphate, a 1,2-diacyl-sn-glycerol and a proton. This reaction is central to phosphoinositide signaling because it converts a membrane lipid into two products that can act as second messengers or signaling precursors. Researchers annotate this activity when an enzyme directly cleaves the phosphodiester bond of phosphatidylinositol, distinguishing it from phospholipases that prefer other lipid headgroups. The activity matters because it connects membrane lipid metabolism to calcium mobilization, immune signaling and neuronal function. Bacterial enzymes with this activity can potentiate lung injury through complement sensitisation, showing that the same catalytic function can be deployed as a virulence mechanism. In plants, phosphatidylinositol-specific phospholipase C is positioned at the center of innate immunity and participates in calcium influx under stress conditions. In humans, primary phospholipase C enzymes are associated with brain disorders, and phospholipase C epsilon 1 has been implicated in beta-amyloid-associated cognitive impairment and pyroptosis in Alzheimer disease models. Because the term is defined by a chemical reaction rather than by a single protein family, it is studied across microbiology, plant biology and human genetics. Small-molecule inhibitors built on a myo-inositol scaffold have been developed to probe phosphatidylinositol-specific phospholipase C function, and gain-of-function variation in PLCG1 causes a new immune dysregulation disease. These examples show why GO:0120548 is a useful anchor for comparing lipid-signaling mechanisms across organisms and for designing CRISPR-based experiments that test causality.
phosphatidylinositol phospholipase C activity At A Glance
| GO ID | GO:0120548 |
|---|---|
| GO term | phosphatidylinositol phospholipase C activity |
| Ontology | molecular_function |
| Synonym | phosphatidylinositol phospholipase C-type activity |
| Major function | Catalysis of phosphatidylinositol hydrolysis to inositol 1-phosphate and diacylglycerol |
| Reaction substrate | 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) |
| Reaction products | 1D-myo-inositol 1-phosphate, 1,2-diacyl-sn-glycerol and H+ |
| Representative enzymes | Bacterial phosphatidylinositol-specific phospholipase C and eukaryotic phospholipase C isoforms |
| Related biology | Phosphoinositide signaling, calcium mobilization, innate immunity and neuronal function |
What Is GO:0120548?
In plain terms, GO:0120548 phosphatidylinositol phospholipase C activity is the enzyme function that cuts a phosphatidylinositol lipid into two pieces by adding water. The official definition states that it catalyzes the reaction: a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) plus H2O yields 1D-myo-inositol 1-phosphate plus a 1,2-diacyl-sn-glycerol plus H+. This is a phosphodiesterase-type cleavage of a phosphatidylinositol substrate, and the synonym phosphatidylinositol phospholipase C-type activity reflects that chemistry. The term is a molecular_function, so it describes what an enzyme does at the reaction level rather than where it acts or which pathway it belongs to.
Why Is phosphatidylinositol phospholipase C activity Important in Cell Biology?
GO:0120548 is important because it defines a lipid-hydrolyzing activity that sits at the intersection of membrane biochemistry and signal transduction. The reaction products, inositol 1-phosphate and diacylglycerol, are directly relevant to calcium signaling and lipid second-messenger biology, which is why the activity is studied in plant immunity, bacterial pathogenesis and human neurological disease. Pharmacological tools such as myo-inositol-scaffold inhibitors and human genetic evidence from PLCG1 gain-of-function disease further show that this activity is druggable and clinically relevant. For researchers, the term provides a precise annotation target when they want to distinguish phosphatidylinositol-specific phospholipase C function from other phospholipase activities.
• Defines a specific lipid phosphodiesterase reaction that generates inositol 1-phosphate and diacylglycerol.
• Provides a molecular_function annotation for enzymes acting on phosphatidylinositol rather than other phospholipids.
• Links membrane lipid metabolism to calcium influx in plant stress and immunity responses.
• Explains a bacterial virulence mechanism that potentiates lung injury via complement sensitisation.
• Connects primary phospholipase C function to brain disorders and neuronal signaling.
• Supports Alzheimer disease research through phospholipase C epsilon 1 effects on beta-amyloid-associated cognitive impairment and pyroptosis.
• Provides a target for myo-inositol-scaffold inhibitors that probe phosphatidylinositol-specific phospholipase C function.
• Is relevant to immune dysregulation caused by gain-of-function variation in PLCG1.
• Enables cross-species comparison of lipid signaling mechanisms in bacteria, plants and mammals.
• Guides CRISPR-based causal tests of candidate genes in lipid-signaling pathways.
Molecular Mechanism of phosphatidylinositol phospholipase C activity
Substrate recognition and membrane association
In simple terms: The enzyme must first find and bind its lipid substrate in a membrane.
Phosphatidylinositol phospholipase C activity is defined by the use of a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) substrate, so the enzyme must recognize the inositol headgroup and the diacylglycerol backbone within a membrane environment. This substrate specificity distinguishes the activity from phospholipases that cleave other phospholipid classes. In plants, phosphatidylinositol-specific phospholipase C is positioned at the center of innate immunity, where substrate availability and membrane context influence signaling output. Bacterial phosphatidylinositol-specific phospholipase C can act on host lipids and potentiate lung injury through complement sensitisation, illustrating that membrane association is functionally important beyond the catalytic step itself.
Catalytic hydrolysis of the phosphodiester bond
In simple terms: Water is used to split the lipid into two products.
The catalytic event is the hydrolysis of the phosphodiester bond in phosphatidylinositol, producing 1D-myo-inositol 1-phosphate, a 1,2-diacyl-sn-glycerol and H+. This reaction is a phospholipase C-type cleavage, and the synonym phosphatidylinositol phospholipase C-type activity reflects that chemistry. The enzyme can also act toward inositol 1,2-(cyclic)-phosphate, indicating that cyclic inositol phosphate species are relevant to the catalytic mechanism and product profile. Because the reaction generates diacylglycerol, the activity is mechanistically connected to lipid second-messenger production.
Product formation and downstream signaling
In simple terms: The products of the reaction can trigger further cellular signals.
The immediate products of GO:0120548 are inositol 1-phosphate, diacylglycerol and a proton. In plant systems, phosphatidylinositol-specific phospholipase C-associated phospholipid metabolism mediates DcGLRs channel activity to promote calcium influx under CaCl2 treatment in shredded carrots during storage. In human cells, primary phospholipase C enzymes are linked to brain disorders, consistent with the idea that the products of this activity feed into neuronal signaling pathways. Phospholipase C epsilon 1 aggravates beta-amyloid-associated cognitive impairments and pyroptosis through activating the RAC1-STAT3 pathway in Alzheimer disease models, showing that downstream signaling from phospholipase C activity can influence cell-death and inflammatory programs.
Regulation by inhibitors and genetic variation
In simple terms: The activity can be turned up or down by drugs and by mutations.
Inhibitors of phosphatidylinositol-specific phospholipase C with a myo-inositol scaffold have been developed, providing chemical tools to modulate this activity. On the genetic side, a gain-of-function variation in PLCG1 causes a new immune dysregulation disease, demonstrating that altered phospholipase C signaling can have clinical consequences. These two lines of evidence show that GO:0120548 is not only a biochemical annotation but also a regulatory node that can be perturbed pharmacologically or genetically.
Cross-species roles in immunity and disease
In simple terms: The same activity appears in bacteria, plants and humans with different outcomes.
Staphylococcal phosphatidylinositol-specific phospholipase C potentiates lung injury via complement sensitisation, showing a bacterial pathogenic role for this activity. Plant phosphatidylinositol-specific phospholipase C is at the center of plant innate immunity, linking the activity to defense signaling. In humans, primary phospholipase C and phospholipase C epsilon 1 are associated with brain disorders and Alzheimer disease models, respectively. Together, these findings illustrate that GO:0120548 describes a conserved catalytic function that is deployed in diverse biological contexts.
Key Genes Involved in GO:0120548 phosphatidylinositol phospholipase C activity
The following genes and proteins are representative of phosphatidylinositol phospholipase C activity and its signaling context across bacteria, plants and humans.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PLCG1 | Phospholipase C gamma 1 signaling | Gain-of-function variation causes immune dysregulation disease |
| PLCE1 | Phospholipase C epsilon 1 signaling | Aggravates beta-amyloid-associated cognitive impairment and pyroptosis in Alzheimer models |
| PLCB1 | Primary phospholipase C in brain | Linked to brain disorders |
| PLCB2 | Primary phospholipase C isoform | Studied in phospholipase C biology and brain disorders |
| PLCB3 | Primary phospholipase C isoform | Studied in phospholipase C biology and brain disorders |
| PLCB4 | Primary phospholipase C isoform | Studied in phospholipase C biology and brain disorders |
| PLCD1 | Phospholipase C delta 1 | Relevant to phosphatidylinositol phospholipase C activity annotation |
| PLCD3 | Phospholipase C delta 3 | Relevant to phosphatidylinositol phospholipase C activity annotation |
| PLCD4 | Phospholipase C delta 4 | Relevant to phosphatidylinositol phospholipase C activity annotation |
| PLCG2 | Phospholipase C gamma 2 | Immune signaling context for phospholipase C activity |
| PLCH1 | Phospholipase C eta 1 | Phospholipase C family member relevant to lipid signaling |
| PLCH2 | Phospholipase C eta 2 | Phospholipase C family member relevant to lipid signaling |
| PLCL1 | Phospholipase C-like 1 | Phospholipase C family member relevant to lipid signaling |
| PLCL2 | Phospholipase C-like 2 | Phospholipase C family member relevant to lipid signaling |
| DcGLRs | Plant calcium channel linked to phospholipid metabolism | Mediates calcium influx under CaCl2 treatment in shredded carrots |
| PI-PLC (bacterial) | Bacterial phosphatidylinositol-specific phospholipase C | Potentiates lung injury via complement sensitisation |
| Plant PI-PLC | Plant phosphatidylinositol-specific phospholipase C | Central to plant innate immunity |
How Is phosphatidylinositol phospholipase C activity Regulated?
Regulation of phosphatidylinositol phospholipase C activity can be studied at the level of chemical inhibition, genetic variation and pathway context. Inhibitors with a myo-inositol scaffold have been developed to target phosphatidylinositol-specific phospholipase C, showing that the activity is pharmacologically tractable. Gain-of-function variation in PLCG1 causes a new immune dysregulation disease, indicating that genetic changes in phospholipase C signaling can alter immune regulation. In Alzheimer disease models, phospholipase C epsilon 1 aggravates beta-amyloid-associated cognitive impairments and pyroptosis through activating the RAC1-STAT3 pathway, providing an example of downstream pathway regulation. In plants, phosphatidylinositol-specific phospholipase C-associated phospholipid metabolism mediates DcGLRs channel activity to promote calcium influx under CaCl2 treatment, linking the activity to stress-responsive calcium regulation. These examples show that regulation can occur through inhibitors, mutations and pathway-level interactions rather than through a single universal mechanism.
phosphatidylinositol phospholipase C activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PLCG1 | Immune dysregulation disease | Knock-in of gain-of-function variant in immune cells |
| PLCE1 | Alzheimer disease-related cognitive impairment and pyroptosis | Overexpression or knockout in neuronal cell models |
| PLCB1 | Brain disorders | Knockout and point-mutation models in neuronal cells |
| Bacterial PI-PLC | Lung injury via complement sensitisation | Bacterial infection models with phospholipase C deletion |
| Plant PI-PLC | Plant innate immunity and calcium influx | Plant knockout and stress-treatment models |
Immune dysregulation and PLCG1 gain-of-function
A gain-of-function variation in PLCG1 causes a new immune dysregulation disease, directly connecting phospholipase C signaling to human immune pathology. This finding is important because it shows that increased activity in a phospholipase C pathway can be pathogenic rather than simply a biochemical curiosity. Researchers studying GO:0120548 can use this disease as a genetic anchor when interpreting variants in phospholipase C genes.
Alzheimer disease and phospholipase C epsilon 1
Phospholipase C epsilon 1 aggravates beta-amyloid-associated cognitive impairments and pyroptosis through activating the RAC1-STAT3 pathway in Alzheimer disease models. This links phospholipase C activity to neuroinflammation and cell-death programs in a neurodegenerative context. The finding supports the idea that lipid-signaling enzymes can influence disease progression beyond their immediate catalytic products.
Brain disorders and primary phospholipase C
Primary phospholipase C enzymes have been associated with brain disorders, indicating that phospholipase C signaling is relevant to neuronal function and neurological disease. This association broadens the disease relevance of GO:0120548 beyond immune and neurodegenerative contexts. It also motivates genetic and pharmacological studies of phospholipase C isoforms in neuronal models.
Bacterial virulence and lung injury
Staphylococcal phosphatidylinositol-specific phospholipase C potentiates lung injury via complement sensitisation, showing that a bacterial enzyme with this activity can act as a virulence factor. This example demonstrates that GO:0120548 is not limited to host signaling and can be studied in infectious disease models. It also highlights complement sensitisation as a downstream mechanism linking the activity to tissue damage.
From phosphatidylinositol phospholipase C activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a phospholipase C gene alter lipid signaling? | CRISPR knockout cell line |
| Does a specific PLCG1 variant cause immune dysregulation? | Point-mutation knock-in model |
| Can a tagged phospholipase C enzyme be tracked in cells? | Tagged knock-in cell line |
| Does overexpression of PLCE1 worsen beta-amyloid-associated phenotypes? | Overexpression cell model |
| Does bacterial phosphatidylinositol-specific phospholipase C drive lung injury? | Bacterial deletion and infection model |
| Does plant phosphatidylinositol-specific phospholipase C regulate calcium influx? | Plant knockout and CaCl2 treatment model |
How to Study the phosphatidylinositol phospholipase C activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipid chromatography or mass spectrometry | Phosphatidylinositol and product levels | Direct assay of GO:0120548 reaction |
| Calcium imaging | Calcium influx and signaling | Plant and mammalian phospholipase C studies |
| CRISPR knockout | Loss-of-function effects | Testing gene requirement in lipid signaling |
| Point-mutation knock-in | Effect of specific variants | Modeling PLCG1 gain-of-function disease |
| Overexpression | Gain-of-function effects | Studying PLCE1 in Alzheimer models |
| Bacterial infection models | Host tissue injury | Testing bacterial phosphatidylinositol-specific phospholipase C virulence |
| Inhibitor treatment | Acute modulation of enzyme activity | Probing phosphatidylinositol-specific phospholipase C function |
| Plant stress treatment | Calcium influx under CaCl2 | Studying plant phospholipase C in storage stress |
Lipid substrate and product analysis
Because GO:0120548 is defined by a chemical reaction, direct measurement of substrate consumption and product formation is a core method. Researchers can use lipid extraction followed by chromatography or mass spectrometry to detect phosphatidylinositol, inositol 1-phosphate and diacylglycerol. The ability of the enzyme to act toward inositol 1,2-(cyclic)-phosphate also suggests that cyclic inositol phosphate species may be informative readouts in mechanistic assays.
Calcium imaging and signaling assays
Phosphatidylinositol-specific phospholipase C-associated phospholipid metabolism mediates DcGLRs channel activity to promote calcium influx under CaCl2 treatment in shredded carrots during storage, making calcium imaging a relevant method for studying this activity in plants. In mammalian systems, the connection between phospholipase C signaling and neuronal function supports the use of calcium and signaling assays in brain-related models. These approaches help link the catalytic activity to downstream cellular responses.
Genetic perturbation and disease modeling
Gain-of-function variation in PLCG1 causes a new immune dysregulation disease, so genetic perturbation is a key method for testing causality. Phospholipase C epsilon 1 aggravates beta-amyloid-associated cognitive impairments and pyroptosis through activating the RAC1-STAT3 pathway in Alzheimer disease models, supporting the use of disease-relevant cell and animal models. Primary phospholipase C has been associated with brain disorders, which further motivates genetic studies in neuronal systems.
Pharmacological inhibition
Inhibitors of phosphatidylinositol-specific phospholipase C with a myo-inositol scaffold provide chemical tools to modulate the activity in cells and biochemical assays. Such inhibitors can be used to test whether a phenotype depends on phosphatidylinositol phospholipase C activity rather than on a related enzyme function. Combining inhibitors with genetic perturbation can strengthen causal inference in pathway studies.
How CRISPR Can Be Used to Study GO:0120548 phosphatidylinositol phospholipase C activity
Knockout
CRISPR knockout can remove a candidate phospholipase C gene to test whether GO:0120548 activity is required for a phenotype. In bacterial systems, deletion of phosphatidylinositol-specific phospholipase C can be used to test its role in lung injury and complement sensitisation. In plants, knockout of phosphatidylinositol-specific phospholipase C can be combined with CaCl2 treatment to assess calcium influx responses.
Point Mutation
Point-mutation knock-in is especially relevant for phospholipase C disease genetics because a gain-of-function variation in PLCG1 causes a new immune dysregulation disease. Introducing the specific disease-associated variant into a cell model allows researchers to compare signaling and immune phenotypes against wild-type controls. This approach can also be used to dissect catalytic residues implicated in the phosphatidylinositol phospholipase C reaction.
Knock-in
Tagged knock-in can place a fluorescent or affinity tag on an endogenous phospholipase C gene to track protein localization and interactions without overexpression artifacts. This is useful for studying membrane recruitment and substrate access, which are central to phosphatidylinositol phospholipase C activity. Knock-in models can also be designed to express disease-relevant variants under native regulatory control.
Overexpression
Overexpression of phospholipase C genes can test gain-of-function effects, as shown by phospholipase C epsilon 1 aggravating beta-amyloid-associated cognitive impairments and pyroptosis in Alzheimer disease models. Overexpression can also be used to amplify signal for biochemical detection of phosphatidylinositol phospholipase C products. Comparing overexpression with knockout phenotypes helps determine the direction of the pathway effect.
How EDITGENE Supports phosphatidylinositol phospholipase C activity Research
Researchers studying phosphatidylinositol phospholipase C activity-related genes often need to determine whether a candidate gene is causally involved in lipid signaling, calcium mobilization or disease phenotypes. EDITGENE provides CRISPR-based cell models and screening services that allow teams to move from correlation to causal evidence using knockout, point-mutation, knock-in and overexpression strategies.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylinositol phospholipase C activity research.
Frequently Asked Questions About phosphatidylinositol phospholipase C activity
What is phosphatidylinositol phospholipase C activity?
It is the Gene Ontology molecular_function GO:0120548, which catalyzes the hydrolysis of phosphatidylinositol into inositol 1-phosphate, diacylglycerol and H+.
What is the GO ID for phosphatidylinositol phospholipase C activity?
The GO ID is GO:0120548, and the official name is phosphatidylinositol phospholipase C activity.
What reaction does GO:0120548 catalyze?
It catalyzes the reaction of a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) with water to produce 1D-myo-inositol 1-phosphate, a 1,2-diacyl-sn-glycerol and H+.
What genes are involved in phosphatidylinositol phospholipase C activity?
Representative genes include PLCG1, PLCE1, PLCB1 and other phospholipase C family members, as well as bacterial and plant phosphatidylinositol-specific phospholipase C enzymes.
How is phosphatidylinositol phospholipase C activity linked to disease?
It has been linked to immune dysregulation through PLCG1 gain-of-function variation, to Alzheimer disease models through PLCE1, to brain disorders through primary phospholipase C, and to lung injury through bacterial phosphatidylinositol-specific phospholipase C.
Can phosphatidylinositol phospholipase C activity be inhibited?
Yes, inhibitors of phosphatidylinositol-specific phospholipase C with a myo-inositol scaffold have been developed as chemical tools.
What is the role of phosphatidylinositol-specific phospholipase C in plants?
Plant phosphatidylinositol-specific phospholipase C is at the center of plant innate immunity and is associated with calcium influx under CaCl2 treatment in shredded carrots during storage.
How can CRISPR be used to study phosphatidylinositol phospholipase C activity?
CRISPR knockout, point-mutation, knock-in and overexpression models can test whether specific phospholipase C genes are required for or sufficient to drive lipid signaling and disease phenotypes.
What methods measure phosphatidylinositol phospholipase C activity?
Lipid substrate and product analysis, calcium imaging, genetic perturbation and pharmacological inhibition are commonly used approaches.
Why is phosphatidylinositol phospholipase C activity important for Alzheimer disease research?
Phospholipase C epsilon 1 aggravates beta-amyloid-associated cognitive impairments and pyroptosis through activating the RAC1-STAT3 pathway in Alzheimer disease models.
Conclusion
GO:0120548 phosphatidylinositol phospholipase C activity defines a precise lipid-hydrolyzing reaction that produces inositol 1-phosphate and diacylglycerol, placing it at the center of phosphoinositide signaling. Its relevance spans bacterial virulence, plant immunity and human disease, including immune dysregulation, brain disorders and Alzheimer disease models. Because the activity can be modulated by myo-inositol-scaffold inhibitors and by disease-associated genetic variants, it is a strong candidate for CRISPR-based causal studies. For research teams, the most informative strategy is to combine biochemical measurement of the reaction with genetic perturbation in relevant cell models. Knockout, point-mutation, knock-in and overexpression models each address a different causal question, and together they can clarify how phosphatidylinositol phospholipase C activity contributes to normal physiology and disease.
References
- 1. Bierkamp C et al.. 2026. Inhibitors of Phosphatidylinositol-specific Phospholipase C wit h Myo-inositol Scaffold.. Med Chem 22(2):150-173 PMID: 40325542
- 2. Lin YC et al.. 2019. Staphylococcal phosphatidylinositol-specific phospholipase C potentiates lung injury via complement sensitisation.. Cell Microbiol 21(10):e13085 PMID: 31290210
- 3. Zhang J et al.. 2024. Phosphatidylinositol-specific phospholipase C-associated phospholipid metabolism mediates DcGLRs channel to promote calcium influx under CaCl(2) treatment in shredded carrots during storage.. Int J Biol Macromol 270(Pt 2):132517 PMID: 38777008
- 4. Abd-El-Haliem AM et al.. 2017. Plant phosphatidylinositol-specific phospholipase C at the center of plant innate immunity.. J Integr Plant Biol 59(3):164-179 PMID: 28097830
- 5. Yang YR et al.. 2016. Primary phospholipase C and brain disorders.. Adv Biol Regul 61:80-5 PMID: 26639088
- 6. Zhou C et al.. 1997. Activation of phosphatidylinositol-specific phospholipase C toward inositol 1,2-(cyclic)-phosphate.. Biochemistry 36(2):347-55 PMID: 9003187
- 7. Pei L et al.. 2025. Phospholipase C epsilon 1 aggravates β-amyloid-associated cognitive impairments and pyroptosis through activating the RAC1-STAT3 pathway in Alzheimer disease models.. J Neuropathol Exp Neurol 84(8):734-745 PMID: 40402834
- 8. Tao P et al.. 2023. A gain-of-function variation in PLCG1 causes a new immune dysregulation disease.. J Allergy Clin Immunol 152(5):1292-1302 PMID: 37422272
